Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder

M. Hornig, T. Briese, J. Licinio, R. F. Khabbaz, L. L. Altshuler, S. G. Potkin, M. Schwemmle, U. Siemetzki, Jim Mintz, K. Honkavuori, H. C. Kraemer, M. F. Egan, P. C. Whybrow, W. E. Bunney, W. I. Lipkin

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

In 1983, reports of antibodies in subjects with major depressive disorder (MDD) to an as-yet uncharacterized infectious agent associated with meningoencephalitis in horses and sheep led to molecular cloning of the genome of a novel, negative-stranded neurotropic virus, Borna disease virus (BDV). This advance has enabled the development of new diagnostic assays, including in situ hybridization, PCR and serology based on recombinant proteins. Since these assays were first implemented in 1990, more than 80 studies have reported an association between BDV and a wide range of human illnesses that include MDD, bipolar disorder (BD), schizophrenia (SZ), anxiety disorder, chronic fatigue syndrome, multiple sclerosis, amyotrophic lateral sclerosis, dementia and glioblastoma multiforme. However, to date there has been no blinded case-control study of the epidemiology of BDV infection. Here, in a United States-based, multi-center, yoked case-control study with standardized methods for clinical assessment and blinded serological and molecular analysis, we report the absence of association of psychiatric illness with antibodies to BDV or with BDV nucleic acids in serially collected serum and white blood cell samples from 396 subjects, a study population comprised of 198 matched pairs of patients and healthy controls (52 SZ/control pairs, 66 BD/control pairs and 80 MDD/control pairs). Our results argue strongly against a role for BDV in the pathogenesis of these psychiatric disorders.

Original languageEnglish (US)
Pages (from-to)486-493
Number of pages8
JournalMolecular Psychiatry
Volume17
Issue number5
DOIs
StatePublished - May 2012
Externally publishedYes

Fingerprint

Bornaviridae
Borna disease virus
Major Depressive Disorder
Bipolar Disorder
Schizophrenia
Infection
Psychiatry
Case-Control Studies
Chronic Fatigue Syndrome
Meningoencephalitis
Antibodies
Amyotrophic Lateral Sclerosis
Molecular Cloning
Virus Diseases
Serology
Glioblastoma
Anxiety Disorders
Recombinant Proteins
Nucleic Acids
Horses

Keywords

  • affective disorders
  • Borna disease virus
  • infection
  • pathogenesis
  • schizophrenia

ASJC Scopus subject areas

  • Molecular Biology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Cite this

Hornig, M., Briese, T., Licinio, J., Khabbaz, R. F., Altshuler, L. L., Potkin, S. G., ... Lipkin, W. I. (2012). Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Molecular Psychiatry, 17(5), 486-493. https://doi.org/10.1038/mp.2011.179

Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. / Hornig, M.; Briese, T.; Licinio, J.; Khabbaz, R. F.; Altshuler, L. L.; Potkin, S. G.; Schwemmle, M.; Siemetzki, U.; Mintz, Jim; Honkavuori, K.; Kraemer, H. C.; Egan, M. F.; Whybrow, P. C.; Bunney, W. E.; Lipkin, W. I.

In: Molecular Psychiatry, Vol. 17, No. 5, 05.2012, p. 486-493.

Research output: Contribution to journalArticle

Hornig, M, Briese, T, Licinio, J, Khabbaz, RF, Altshuler, LL, Potkin, SG, Schwemmle, M, Siemetzki, U, Mintz, J, Honkavuori, K, Kraemer, HC, Egan, MF, Whybrow, PC, Bunney, WE & Lipkin, WI 2012, 'Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder', Molecular Psychiatry, vol. 17, no. 5, pp. 486-493. https://doi.org/10.1038/mp.2011.179
Hornig, M. ; Briese, T. ; Licinio, J. ; Khabbaz, R. F. ; Altshuler, L. L. ; Potkin, S. G. ; Schwemmle, M. ; Siemetzki, U. ; Mintz, Jim ; Honkavuori, K. ; Kraemer, H. C. ; Egan, M. F. ; Whybrow, P. C. ; Bunney, W. E. ; Lipkin, W. I. / Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. In: Molecular Psychiatry. 2012 ; Vol. 17, No. 5. pp. 486-493.
@article{33b33ddefe4a4ab8bfaa5f210381929e,
title = "Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder",
abstract = "In 1983, reports of antibodies in subjects with major depressive disorder (MDD) to an as-yet uncharacterized infectious agent associated with meningoencephalitis in horses and sheep led to molecular cloning of the genome of a novel, negative-stranded neurotropic virus, Borna disease virus (BDV). This advance has enabled the development of new diagnostic assays, including in situ hybridization, PCR and serology based on recombinant proteins. Since these assays were first implemented in 1990, more than 80 studies have reported an association between BDV and a wide range of human illnesses that include MDD, bipolar disorder (BD), schizophrenia (SZ), anxiety disorder, chronic fatigue syndrome, multiple sclerosis, amyotrophic lateral sclerosis, dementia and glioblastoma multiforme. However, to date there has been no blinded case-control study of the epidemiology of BDV infection. Here, in a United States-based, multi-center, yoked case-control study with standardized methods for clinical assessment and blinded serological and molecular analysis, we report the absence of association of psychiatric illness with antibodies to BDV or with BDV nucleic acids in serially collected serum and white blood cell samples from 396 subjects, a study population comprised of 198 matched pairs of patients and healthy controls (52 SZ/control pairs, 66 BD/control pairs and 80 MDD/control pairs). Our results argue strongly against a role for BDV in the pathogenesis of these psychiatric disorders.",
keywords = "affective disorders, Borna disease virus, infection, pathogenesis, schizophrenia",
author = "M. Hornig and T. Briese and J. Licinio and Khabbaz, {R. F.} and Altshuler, {L. L.} and Potkin, {S. G.} and M. Schwemmle and U. Siemetzki and Jim Mintz and K. Honkavuori and Kraemer, {H. C.} and Egan, {M. F.} and Whybrow, {P. C.} and Bunney, {W. E.} and Lipkin, {W. I.}",
year = "2012",
month = "5",
doi = "10.1038/mp.2011.179",
language = "English (US)",
volume = "17",
pages = "486--493",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder

AU - Hornig, M.

AU - Briese, T.

AU - Licinio, J.

AU - Khabbaz, R. F.

AU - Altshuler, L. L.

AU - Potkin, S. G.

AU - Schwemmle, M.

AU - Siemetzki, U.

AU - Mintz, Jim

AU - Honkavuori, K.

AU - Kraemer, H. C.

AU - Egan, M. F.

AU - Whybrow, P. C.

AU - Bunney, W. E.

AU - Lipkin, W. I.

PY - 2012/5

Y1 - 2012/5

N2 - In 1983, reports of antibodies in subjects with major depressive disorder (MDD) to an as-yet uncharacterized infectious agent associated with meningoencephalitis in horses and sheep led to molecular cloning of the genome of a novel, negative-stranded neurotropic virus, Borna disease virus (BDV). This advance has enabled the development of new diagnostic assays, including in situ hybridization, PCR and serology based on recombinant proteins. Since these assays were first implemented in 1990, more than 80 studies have reported an association between BDV and a wide range of human illnesses that include MDD, bipolar disorder (BD), schizophrenia (SZ), anxiety disorder, chronic fatigue syndrome, multiple sclerosis, amyotrophic lateral sclerosis, dementia and glioblastoma multiforme. However, to date there has been no blinded case-control study of the epidemiology of BDV infection. Here, in a United States-based, multi-center, yoked case-control study with standardized methods for clinical assessment and blinded serological and molecular analysis, we report the absence of association of psychiatric illness with antibodies to BDV or with BDV nucleic acids in serially collected serum and white blood cell samples from 396 subjects, a study population comprised of 198 matched pairs of patients and healthy controls (52 SZ/control pairs, 66 BD/control pairs and 80 MDD/control pairs). Our results argue strongly against a role for BDV in the pathogenesis of these psychiatric disorders.

AB - In 1983, reports of antibodies in subjects with major depressive disorder (MDD) to an as-yet uncharacterized infectious agent associated with meningoencephalitis in horses and sheep led to molecular cloning of the genome of a novel, negative-stranded neurotropic virus, Borna disease virus (BDV). This advance has enabled the development of new diagnostic assays, including in situ hybridization, PCR and serology based on recombinant proteins. Since these assays were first implemented in 1990, more than 80 studies have reported an association between BDV and a wide range of human illnesses that include MDD, bipolar disorder (BD), schizophrenia (SZ), anxiety disorder, chronic fatigue syndrome, multiple sclerosis, amyotrophic lateral sclerosis, dementia and glioblastoma multiforme. However, to date there has been no blinded case-control study of the epidemiology of BDV infection. Here, in a United States-based, multi-center, yoked case-control study with standardized methods for clinical assessment and blinded serological and molecular analysis, we report the absence of association of psychiatric illness with antibodies to BDV or with BDV nucleic acids in serially collected serum and white blood cell samples from 396 subjects, a study population comprised of 198 matched pairs of patients and healthy controls (52 SZ/control pairs, 66 BD/control pairs and 80 MDD/control pairs). Our results argue strongly against a role for BDV in the pathogenesis of these psychiatric disorders.

KW - affective disorders

KW - Borna disease virus

KW - infection

KW - pathogenesis

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84860120334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860120334&partnerID=8YFLogxK

U2 - 10.1038/mp.2011.179

DO - 10.1038/mp.2011.179

M3 - Article

VL - 17

SP - 486

EP - 493

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 5

ER -